{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:02:04Z","timestamp":1789740124255,"version":"4.0.1"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"unspecified","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01-HD104646"],"award-info":[{"award-number":["R01-HD104646"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Ment Health"],"accepted":{"date-parts":[[2026,2,9]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medication safety studies in pregnancy typically focus on selected or composite outcomes (eg, any malformation) to test specific hypotheses or verify suspected safety signals, potentially overlooking or masking other clinically significant associations (eg, individual malformations or malformation types).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To conduct a comprehensive, systematic screening for potential teratogenic safety alerts associated with first-trimester exposure to individual antipsychotics, using a tree-based scan statistic (TBSS) approach for simultaneous evaluation of a broad range of specific malformations and malformation groupings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using a US-nationwide cohort of &gt;4.2\u2009million mother\u2013child dyads (2000\u20132020), pregnancies with \u22651 first-trimester antipsychotic dispensing were compared with antipsychotic-unexposed pregnancies. Individual congenital malformations were identified via International Classification of Diseases codes, grouped into increasingly aggregated higher-level clinically related categories. Leveraging this hierarchical classification\n                      <jats:italic>tree<\/jats:italic>\n                      , TBSS was used to\n                      <jats:italic>scan<\/jats:italic>\n                      for associations with individual malformation codes and code categories while tightly controlling type 1 error. Confounding was adjusted for via propensity score fine-stratification, and relative risks (RRs) were estimated using an unconditional Poisson scan statistic. The p-values were used to prioritise alerts for further investigation, and follow-up analyses were conducted to refine the understanding of statistical alerts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Exposed pregnancies ranged from 68 (fluphenazine) to 18\u2009366 (prochlorperazine). Antipsychotic-exposed versus antipsychotic-unexposed women tended to be older and to have a higher comorbidity burden and more healthcare encounters. Alerts for an increased risk (with p&lt;0.1) were observed for skin anomaly after haloperidol (RR=1.88) and polydactyly after ziprasidone (RR=3.06) exposure. Results were consistent in sensitivity analyses. The data in the two external data sources were too sparse to confirm a safety alert.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TBSS identified two potential alerts previously unreported for prenatal antipsychotic exposure. Importantly, no alerts for severe or life-threatening malformations were detected. Findings from this screening-based approach, therefore, align with existing evidence suggesting that antipsychotics are unlikely to be major teratogens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical implications<\/jats:title>\n                    <jats:p>The potential risk increase observed for some less-severe malformations and some antipsychotics needs to be weighed against the high potential for relapse and mental health deterioration following treatment discontinuation. While no consistent patterns suggesting a strong teratogenic effect have emerged thus far for newer antipsychotics, continued monitoring of these medications is important.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjment-2025-302270","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:45:16Z","timestamp":1775666716000},"page":"e302270","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Congenital malformation risk following prenatal antipsychotic exposure: a systematic safety surveillance approach"],"prefix":"10.1136","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2623-2726","authenticated-orcid":false,"given":"Loreen","family":"Straub","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley V","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hernandez-Diaz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T","family":"Bateman","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seanna M","family":"Vine","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Statistics, The Ohio State University, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Cohen","sequence":"additional","affiliation":[{"name":"Center for Women\u2019s Mental Health, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5759-9366","authenticated-orcid":false,"given":"Carolyn E","family":"Cesta","sequence":"additional","affiliation":[{"name":"Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J","family":"Gray","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista F","family":"Huybrechts","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"2026091806102902000_29.1.e302270.1","first-page":"13","article-title":"Use of atypical antipsychotics in refractory depression and anxiety","volume":"66 Suppl 8","author":"Nemeroff","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"2026091806102902000_29.1.e302270.2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1176\/appi.ajp.2018.18010098","article-title":"Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine","volume":"175","author":"Cohen","year":"2018","journal-title":"AJP"},{"key":"2026091806102902000_29.1.e302270.3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jamapsychiatry.2022.4109","article-title":"Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US","volume":"80","author":"Huybrechts","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"2026091806102902000_29.1.e302270.4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"2026091806102902000_29.1.e302270.5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40263-018-0517-5","article-title":"The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review","volume":"32","author":"Damkier","year":"2018","journal-title":"CNS Drugs"},{"key":"2026091806102902000_29.1.e302270.6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bcpt.12372","article-title":"Pregnancy Exposure to Olanzapine, Quetiapine, Risperidone, Aripiprazole and Risk of Congenital Malformations. A Systematic Review","volume":"116","author":"Ennis","year":"2015","journal-title":"Basic Clin Pharma Tox"},{"key":"2026091806102902000_29.1.e302270.7","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1111\/bcp.14839","article-title":"Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children: A systematic review and meta-analysis","volume":"87","author":"Wang","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2026091806102902000_29.1.e302270.8","doi-asserted-by":"crossref","first-page":"100950","DOI":"10.1016\/j.ajogmf.2023.100950","article-title":"Maternal antipsychotic use during pregnancy and congenital malformations","volume":"5","author":"Liu","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2026091806102902000_29.1.e302270.9","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420450206"},{"key":"2026091806102902000_29.1.e302270.10","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.10012"},{"key":"2026091806102902000_29.1.e302270.11","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3423"},{"key":"2026091806102902000_29.1.e302270.12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/aje\/kwac176","article-title":"Sequential Data-Mining for Adverse Events After Recombinant Herpes Zoster Vaccination Using the Tree-Based Scan Statistic","volume":"192","author":"Yih","year":"2023","journal-title":"Am J Epidemiol"},{"key":"2026091806102902000_29.1.e302270.13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/pharmaceutics5010179","article-title":"Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic","volume":"5","author":"Brown","year":"2013","journal-title":"Pharmaceutics"},{"key":"2026091806102902000_29.1.e302270.14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/aje\/kwaa288","article-title":"Active Surveillance of the Safety of Medications Used During Pregnancy","volume":"190","author":"Huybrechts","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2026091806102902000_29.1.e302270.15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/EDE.0000000000001561","article-title":"Monitoring Drug Safety in Pregnancy with Scan Statistics: A Comparison of Two Study Designs","volume":"34","author":"Suarez","year":"2023","journal-title":"Epidemiology"},{"key":"2026091806102902000_29.1.e302270.16","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/aje\/kwae272","article-title":"Hierarchical clustering analysis to inform classification of congenital malformations for surveillance of medication safety in pregnancy","volume":"194","author":"Straub","year":"2025","journal-title":"Am J Epidemiol"},{"key":"2026091806102902000_29.1.e302270.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067405","article-title":"Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations","volume":"8","author":"Palmsten","year":"2013","journal-title":"PLoS One"},{"key":"2026091806102902000_29.1.e302270.18","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4794"},{"key":"2026091806102902000_29.1.e302270.19","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182a603bb"},{"key":"2026091806102902000_29.1.e302270.20","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000595"},{"key":"2026091806102902000_29.1.e302270.21","unstructured":"Kulldorff M . TreeScan: software for the tree-based scan statistic. 2004. Available: https:\/\/www.treescan.org\/"},{"key":"2026091806102902000_29.1.e302270.22","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3627"},{"key":"2026091806102902000_29.1.e302270.23","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181a663cc"},{"key":"2026091806102902000_29.1.e302270.24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.4088\/JCP.14br09418","article-title":"Establishment of the National Pregnancy Registry for Atypical Antipsychotics","volume":"76","author":"Cohen","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"2026091806102902000_29.1.e302270.25","doi-asserted-by":"crossref","unstructured":"Cohen JM , Cesta CE , Kjerpeseth L , et al . A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS). Nor J Epidemiol 2021;29. doi:10.5324\/nje.v29i1-2.4053","DOI":"10.5324\/nje.v29i1-2.4053"},{"key":"2026091806102902000_29.1.e302270.26","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"2026091806102902000_29.1.e302270.27","unstructured":"Holmes LB . Common malformations. 1st edn. Oxford: Oxford University Press, 2012."},{"key":"2026091806102902000_29.1.e302270.28","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.274"},{"key":"2026091806102902000_29.1.e302270.29","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203090-00005"},{"key":"2026091806102902000_29.1.e302270.30","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint14010005"}],"container-title":["BMJ Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjment-2025-302270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:10:59Z","timestamp":1789737059000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/bmjment-2025-302270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,8]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjment-2025-302270"],"URL":"https:\/\/doi.org\/10.1136\/bmjment-2025-302270","relation":{},"ISSN":["2755-9734"],"issn-type":[{"value":"2755-9734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}